Dexamethasone Solution for the Treatment of Oral Lichen Planus

Summary

The objective of this single center, 4-week, open label randomized, phase II study is to evaluate and characterize the tolerability and clinical effectiveness of dexamethasone 0.5mg/5ml solution in a mucoadhesive vehicle (Mucolox™) for the treatment of oral lichen planus.

Timeline

Start

2017-02-07

Primary completion

2019-12-19

Completion

2019-12-20

Drugs

Indications